×
About 1,298 results

ALLMedicine™ Urologic Oncology Center

Research & Reviews  275 results

Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies
https://clinicaltrials.gov/ct2/show/NCT04541030

Aug 11th, 2022 - Background: Prostate cancer is one of the most common malignancies occurring in men. While many men will qualify for active surveillance (AS), those with intermediate risk disease are often recommended definitive therapy despite the morbidity. Foc...

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
https://clinicaltrials.gov/ct2/show/NCT03861676

Aug 5th, 2022 - Current conventional prostate cancer (PCa) imaging modalities (computed tomography, bone scan, magnetic resonance imaging, ultrasound) have limited accuracy in the initial staging and for determining prognosis of PCa. Prostate-specific membrane an...

Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
https://clinicaltrials.gov/ct2/show/NCT02594202

Aug 4th, 2022 - Background: Prostate carcinoma is the second most common malignancy diagnosed in men. Approximately 1 in 6 men will be diagnosed with prostate cancer in their lifetime. Understanding the molecular mechanisms and genomic alterations that cause pros...

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
https://clinicaltrials.gov/ct2/show/NCT00026884

Aug 1st, 2022 - Background Kidney, prostate, bladder, testis and penile cancer account for 22% of cancers diagnosed in the United States and are responsible for 10% of cancer deaths each year in the U.S. Understanding the genes and gene pathways that cause genito...

Fluorescence-guided radical prostatectomy.
https://doi.org/10.1007/s11255-022-03307-0
International Urology and Nephrology; Hasan O, Reed A et. al.

Jul 30th, 2022 - Robotic-assisted laparoscopic radical prostatectomy represents one of the most common operations in urologic oncology and involves several critical technical steps including pelvic lymph node dissection, cavernous nerve sparing and vesicourethral ...

see more →

Guidelines  2 results

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline.
https://doi.org/10.1200/JCO.19.02757
Journal of Clinical Oncology : Official Journal of the Am... Trabulsi EJ, Rumble RB et. al.

Jan 16th, 2020 - Provide evidence- and expert-based recommendations for optimal use of imaging in advanced prostate cancer. Due to increases in research and utilization of novel imaging for advanced prostate cancer, this guideline is intended to outline techniques...

Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Associat...
https://doi.org/10.1200/JOP.2017.024919
Journal of Oncology Practice; Chang SS, Bochner BH et. al.

Aug 11th, 2017 - Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.|2017|Chang S...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  10 results

Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies
https://clinicaltrials.gov/ct2/show/NCT04541030

Aug 11th, 2022 - Background: Prostate cancer is one of the most common malignancies occurring in men. While many men will qualify for active surveillance (AS), those with intermediate risk disease are often recommended definitive therapy despite the morbidity. Foc...

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
https://clinicaltrials.gov/ct2/show/NCT03861676

Aug 5th, 2022 - Current conventional prostate cancer (PCa) imaging modalities (computed tomography, bone scan, magnetic resonance imaging, ultrasound) have limited accuracy in the initial staging and for determining prognosis of PCa. Prostate-specific membrane an...

Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
https://clinicaltrials.gov/ct2/show/NCT02594202

Aug 4th, 2022 - Background: Prostate carcinoma is the second most common malignancy diagnosed in men. Approximately 1 in 6 men will be diagnosed with prostate cancer in their lifetime. Understanding the molecular mechanisms and genomic alterations that cause pros...

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
https://clinicaltrials.gov/ct2/show/NCT00026884

Aug 1st, 2022 - Background Kidney, prostate, bladder, testis and penile cancer account for 22% of cancers diagnosed in the United States and are responsible for 10% of cancer deaths each year in the U.S. Understanding the genes and gene pathways that cause genito...

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
https://clinicaltrials.gov/ct2/show/NCT02379429

Jul 7th, 2022 - Background: Urothelial carcinoma, present as lower or upper urinary tract disease, is the most expensive malignancy to treat from diagnosis to death, and no major advances in drug therapy have taken place in the last two decades. Understanding the...

see more →

News  231 results

How Can ctDNA Testing Improve Bladder Cancer Care?
https://www.medscape.com/viewarticle/970413

Aug 10th, 2022 - This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion. I'm Dr Cheryl Lee. Today we'll be talking about circulating tumor DNA, or ctDNA, testing as the next step in personalized medicine for individuals with ...

Urologists Find AUA Abortion Statement Lacking
https://www.medscape.com/viewarticle/976221

Jun 27th, 2022 - Urologists on social media are urging the American Urological Association (AUA) to strengthen what they feel was a tepid statement from the group in reaction to the US Supreme Court's decision overturning the federal right to abortion. On Saturday...

Ukrainian-Born US Doctor Drops Everything, Heads to the War Zone
https://www.medscape.com/viewarticle/970385

Mar 16th, 2022 - On the first night that Russian forces invaded Ukraine, Laura Bukavina, MD, and her Ukrainian husband decided they had to do something to help their homeland. It was personal. "Being Ukrainian, having family in Ukraine, as well as being the mother...

63% of patients with upper tract urothelial carcinoma respond to chemo before surgery
https://www.mdedge.com/hematology-oncology/article/252162/genitourinary-cancer/63-patients-upper-tract-urothelial-carcinoma
M. Alexander Otto

Feb 24th, 2022 - Investigators presenting at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium called for neoadjuvant chemotherapy to be a new standard of care for high-grade upper tract urothelial carcinoma. They made the call after find.

Investigators Set Their Sights on Optimizing Sequencing With Novel Therapies in GU Cancers
https://www.onclive.com/view/investigators-set-their-sights-on-optimizing-sequencing-with-novel-therapies-in-gu-cancers

Feb 11th, 2022 - Following significant clinical progress, treatment selection and sequencing in genitourinary (GU) cancers, such as metastatic bladder cancer and metastatic renal cell carcinoma (mRCC), have become more complicated and require nuanced decision maki...

see more →